Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 3 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Increased risk of nonrelapse mortality post T-cell-replete haploidentical stem cell transplantation in patients with recurrence of acute graft-versus-host disease.
Hematol Oncol. 2022 Oct;40(4):743-751. doi: 10.1002/hon.2999. Epub 2022 Apr 17.
Hematol Oncol. 2022.
PMID: 35385135
[Effect of ruxolitinib combined with glucocorticoid on cytomegalovirus activation in acute graft-versus-host disease].
Xing SY, Qian K, Zhao YX, Peng B, Yang JJ, Dou LP, Liu DH.
Xing SY, et al.
Zhonghua Xue Ye Xue Za Zhi. 2022 Sep 14;43(9):732-737. doi: 10.3760/cma.j.issn.0253-2727.2022.09.004.
Zhonghua Xue Ye Xue Za Zhi. 2022.
PMID: 36709166
Free PMC article.
Chinese.
Item in Clipboard
Elevated REG3α predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy.
Yang J, Peng B, Wang L, Li X, Li F, Jin X, Jia M, Xu L, Dou L, Liu D.
Yang J, et al.
Ann Hematol. 2022 Mar;101(3):621-630. doi: 10.1007/s00277-021-04727-1. Epub 2021 Nov 23.
Ann Hematol. 2022.
PMID: 34816294
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite